Research Interests
Open to PhD applications in the field of
- Cancer research
- Personalised medicine
- Biomarkers
- Novel treatment options
Current Research Opportunities
- Developing novel therapeutic strategies to better treat Triple Negative Breast Cancer
- Investigating the clinical and molecular significance of the microbiome in breast cancer
Public outreach & key achievements
- Recipient of prestigious Breast Cancer Now Scientific Fellowship 2013 (£550,852)
- EACR Young Scientist,
- Roche Gold Medal for Research,
- School of Medicine, Dentistry and Biomedical Sciences Post Doctoral Researcher of the Year
- BRCALinkNI Annual Patient Information Day
Press Coverage and Impact:
- 14 Sci-tech innovators solving the world’s big problems
- Queen’s scientist to help find new options to treat aggressive breast cancers
- QUB scientists in breast cancer diagnosis breakthrough
- Belfast researchers discover potential new way to better tailor treatments for early breast tumours
- Queen's research raising hopes of 'tailored' breast cancer treatment
- International Women's Day: Nine women who #makeithappen in breast cancer research
- Investigating new ways to identify and treat patients with a poor prognosis
- Investigating PIN1 as a biomarker for BRCA1-mutated breast cancer
Research students
| PhD Title | Identification of Novel Biomarkers and Therapeutic Strategies in Triple Negative Breast Cancer |
| Name | Ahmed Elkashif |
| Country | Northern Ireland |
| Year of Study | 2017-2020 |
| PhD Title | Nano-engineered Systems for the Targeted Delivery of Oncology Drugs for Breast Cancer |
| Name | Kim Glass |
| Country | Northern Ireland |
| Year of Study | 2018-2022 |
| PhD Title | IGNITE: IGnifying Tumours: Nanotechnology for Immune Oncology TargEts |
| Name | Elaine Gilmore |
| Country | Northern Ireland |
| Year of Study | 2019-2022 |
| PhD Title | Investigating the role of CDH1 in Triple Negative Breast Cancer |
| Name | Linbo Gao |
| Country | China |
| Year of Study | 2019-2022 |
Alumni: Where are they now
| PhD Title | Characterisation of the Prolyl Isomerase, Pin1, in BRCA1-deficient Breast Cancer |
| Name | Dr Catherine Knowlson |
| Year of Study | 2014-2017 |
| Country | Scotland |
| Current Position | Research Scientist in CV6 Therapeutics |
| PhD Title | Investigation of the role of the Two Pore Potassium Channels (KCNK) in High Grade Serous Ovarian Cancer |
| Name | Dr Elaine Craig |
| Year of Study | 2015-2017 |
| Country | Northern Ireland |
| Current Position | Consultant Gynae-Oncology Surgeon, Belfast City Hospital |
| PhD Title | POTENT- Personalized Ovarian Cancer Therapy using Gene Editing and Nano-Technology |
| Name | Kathryn Egerton |
| Year of Study | 2018-2019 |
| Country | Northern Ireland |
| Current Position | Research Associate, INI Proof of Concept Grant, School of Pharmacy, QUB l |